May 11 (Reuters) - Cochlear Ltd (COH) :
- COCHLEAR LTD- CONFIRMATION OF COVID-19 PANDEMIC IMPACT ON TRADING
- COCHLEAR - SALES REVENUE ACROSS BUSINESS DECLINED BY ABOUT 60% IN APRIL COMPARED TO APRIL 2019
- COCHLEAR - IN CHINA, SURGERIES RECOMMENCED IN LATE FEB & CONTINUED TO RECOVER THROUGHOUT APRIL
- COCHLEAR- SERVICES BUSINESS ALSO IMPACTED WITH APRIL SALES DECLINING BY ABOUT 30%
- COCHLEAR - REDUCED NON-ESSENTIAL SPENDING & CAPEX UNTIL THERE IS SUSTAINED INCREASE IN SURGERIES
- COCHLEAR - EXPECTING GRADUAL RECOVERY WITH EXPECTATIONS THAT HOSPITALS WILL PROCEED CAUTIOUSLY WITH RESUMPTION OF ELECTIVE SURGERY
- COCHLEAR- SUPPLY CHAIN CONTINUES TO BE LARGELY INTACT WITH NO SUPPLY SHORTAGES EXPECTED FOR COMPONENTS OVER COMING MONTHS
- Forums
- ASX - By Stock
- COH
- News: COH Cochlear Updates On Confirmation Of Covid-19 Pandemic Impact On Trading
COH
cochlear limited
Add to My Watchlist
0.70%
!
$303.78

News: COH Cochlear Updates On Confirmation Of Covid-19 Pandemic Impact On Trading
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$303.78 |
Change
2.120(0.70%) |
Mkt cap ! $19.86B |
Open | High | Low | Value | Volume |
$303.79 | $304.22 | $300.12 | $51.31M | 169.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 77 | $302.32 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$304.30 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 77 | 302.320 |
1 | 57 | 300.680 |
1 | 18 | 300.500 |
1 | 38 | 300.140 |
5 | 705 | 300.000 |
Price($) | Vol. | No. |
---|---|---|
304.300 | 100 | 1 |
304.440 | 50 | 1 |
304.620 | 250 | 1 |
304.800 | 330 | 1 |
304.950 | 5 | 1 |
Last trade - 16.10pm 21/08/2025 (20 minute delay) ? |
Featured News
COH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online